Furthermore, the endogenous inhibitor of GzmB, serine protease inhibitor 6, protects alloreactive T cells from GzmB-mediated mitochondrial damage without affecting graft-versus-tumor effect (41). This evidence concerns the gene GZMB and neoplasm.